$AMGN (Amgen Inc.) Support & Resistance Levels, AI Price Target & Institutional Flow.
Today, $AMGN (Amgen Inc.) trades at $435.64 (-0.15%) with a 62/100 Momentum Pulse (CONSOLIDATION). Unlock the live $AMGN support and resistance levels, 30D Put Wall floor, 20D SMA pivot, Call Wall ceiling, dark pool flow, and locked 1-Month AI Price Target (+14.2% upside corridor) below—or create a free 24/7 AI quant agent to guard $AMGN.
Spot Price: $435.64 | 30-Day Support Floor: its 30-day volume floor (near) | 10-Day EMA: its 20-day moving average | 20-Day SMA Pivot: its 20-day moving average | 30-Day Resistance Ceiling: its 30-day breakout ceiling (approaching) | 14-Day RSI: neutral territory | 30-Day Trading Corridor: Tracked. Value and mean-reversion buyers in Amgen Inc. ($AMGN) are monitoring the its 30-day volume floor 30-day mechanical support floor (spot price at $435.64 sits near support with 14-day RSI at neutral territory). Reclaiming the 10-day EMA (its 20-day moving average) and 20-day SMA pivot (its 20-day moving average) is the primary technical trigger to ignite a move back toward the its 30-day breakout ceiling resistance ceiling.
$AMGN (Amgen Inc.) Live Key Levels, RSI & Valuation Matrix
| $AMGN Technical Metric | Live Value | $AMGN Fundamental / Regime Metric | Live Status |
|---|---|---|---|
| Live Spot Price (24h Change) | $435.64 (-0.15%) | Market Capitalization | $235.52B |
| 30-Day Mechanical Support Floor (Put Wall) | Tracked | 52-Week High / Low Range | $312.38 – $483.99 |
| 20-Day Simple Moving Average (20D SMA) | Tracked | Trailing P/E Ratio & Dividend Yield | 25.08x • Yield: 2.86% |
| 10-Day Exponential Moving Average (10D EMA) | Tracked | Average Daily Volume (Liquidity) | 2.77M shares |
| 30-Day Resistance Ceiling (Call Wall) | Tracked | Next Scheduled Earnings / Catalyst Window | 2026-11-03 |
| 14-Day Relative Strength Index (RSI) | NEUTRAL (50.0) | Saku Momentum Pulse & Health Rating | 62/100 Momentum • 64/100 Health |
Should You Buy $AMGN Stock Now or Wait?
Value and mean-reversion buyers in Amgen Inc. ($AMGN) are monitoring the its 30-day volume floor 30-day mechanical support floor (spot price at $435.64 sits near support with 14-day RSI at neutral territory). Reclaiming the 10-day EMA (its 20-day moving average) and 20-day SMA pivot (its 20-day moving average) is the primary technical trigger to ignite a move back toward the its 30-day breakout ceiling resistance ceiling.
$AMGN (Amgen Inc.) is currently trading below its 20-day simple moving average (its 20-day moving average) after a tracked 30-day move. If buyers fail to defend the 30-day mechanical support floor at its 30-day volume floor (near current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($312.38).
$AMGN Support & Resistance, Institutional Flow & Catalysts.
$AMGN Support & Resistance
Spot Price: $435.64 | 30-Day Support Floor: its 30-day volume floor (near) | 10-Day EMA: its 20-day moving average | 20-Day SMA Pivot: its 20-day moving average | 30-Day Resistance Ceiling: its 30-day breakout ceiling (approaching) | 14-Day RSI: neutral territory | 30-Day Trading Corridor: Tracked.
$AMGN Institutional & Whale Flow
Institutional order flow for $AMGN (averaging 2.77M shares daily volume) is concentrated between the its 30-day volume floor Put Wall support zone and its 30-day breakout ceiling Call Wall resistance ceiling, with a live Saku Fundamental Health score of 64/100.
$AMGN Catalyst Outlook
Next scheduled earnings window for Amgen Inc. ($AMGN): 2026-11-03. Latest tracked headline from simplywall.st: "What Amgen Doubters Got Wrong".
Latest $AMGN (Amgen Inc.) Breaking News & Headlines
About Amgen Inc. ($AMGN)
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions. Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
Saku's quantitative engine continuously monitors $AMGN's 30-day mechanical support floor (active floor), 20-day simple moving average (active pivot), and 30-day resistance ceiling (active ceiling) alongside off-exchange dark pool block prints and SEC filings.
Hatch Your Own 24/7 AI Co-Pilot to Guard $AMGN.
Step inside the 3D Quant Sanctuary and claim Workstation #4 to hatch your personal AI analyst (Momentum, Dip-Buyer, or Value & Catalyst style). Your agent monitors $AMGN 24/7 with locked 1-month price targets, hard stop-loss tripwires, 3x/day shift briefings, and live Koi Bridge debates.

What are the live 30-day support and resistance levels for $AMGN (Amgen Inc.)?
Spot Price: $435.64 | 30-Day Support Floor: its 30-day volume floor (near) | 10-Day EMA: its 20-day moving average | 20-Day SMA Pivot: its 20-day moving average | 30-Day Resistance Ceiling: its 30-day breakout ceiling (approaching) | 14-Day RSI: neutral territory | 30-Day Trading Corridor: Tracked. $AMGN currently registers a Saku Momentum Pulse score of 62/100 and a Fundamental Health score of 64/100.
Why is $AMGN (Amgen Inc.) moving and what is the bull vs. bear thesis?
Bull Thesis: Value and mean-reversion buyers in Amgen Inc. ($AMGN) are monitoring the its 30-day volume floor 30-day mechanical support floor (spot price at $435.64 sits near support with 14-day RSI at neutral territory). Reclaiming the 10-day EMA (its 20-day moving average) and 20-day SMA pivot (its 20-day moving average) is the primary technical trigger to ignite a move back toward the its 30-day breakout ceiling resistance ceiling. Bear Thesis: $AMGN (Amgen Inc.) is currently trading below its 20-day simple moving average (its 20-day moving average) after a tracked 30-day move. If buyers fail to defend the 30-day mechanical support floor at its 30-day volume floor (near current spot), negative dealer gamma hedging can accelerate downside discovery toward the lower end of its 52-week range ($312.38).
What are $AMGN's key fundamentals, 52-week range, and upcoming catalysts?
Amgen Inc. ($AMGN) trades with a market cap of $235.52B, a P/E ratio of 25.08x, and a 52-week range of $312.38 to $483.99. Next scheduled earnings window for Amgen Inc. ($AMGN): 2026-11-03. Latest tracked headline from simplywall.st: "What Amgen Doubters Got Wrong".